Related Experiment Video

Updated: Aug 9, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis

Brendan D Manning1

  • 1Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA. bmanning@hsph.harvard.edu

The Journal of Cell Biology
|November 10, 2004
PubMed

Insights

The phosphoinositide 3-kinase-Akt pathway is crucial for preventing insulin resistance and cancer. A newly found feedback loop involving mTOR and S6K inhibits pathway activation, impacting metabolic diseases and tumors.

Area of Science:

  • Biochemistry and Molecular Biology
  • Cell Signaling
  • Metabolic and Cancer Research

Background:

  • The phosphoinositide 3-kinase-Akt pathway plays a critical role in cellular processes, including metabolism and cell growth.
  • Dysregulation of this pathway is implicated in metabolic diseases like diabetes and obesity, as well as in various forms of cancer.
  • Understanding the regulatory mechanisms of this pathway is essential for therapeutic interventions.

Purpose of the Study:

  • To characterize a negative feedback loop within the phosphoinositide 3-kinase-Akt pathway.
  • To elucidate the role of mammalian target of rapamycin (mTOR) and ribosomal S6 kinase (S6K) in regulating pathway activation.
  • To explore the implications of this feedback loop in metabolic diseases and tumorigenesis.

Main Methods:

  • Investigated the interactions between downstream components of the phosphoinositide 3-kinase-Akt pathway.
  • Utilized molecular biology techniques to study the inhibitory effects of mTOR and S6K.
  • Analyzed the impact of this feedback mechanism on insulin receptor substrate (IRS) function.

Main Results:

  • Identified a negative feedback loop where mTOR and S6K inhibit upstream activation of the phosphoinositide 3-kinase-Akt pathway.
  • Demonstrated that this feedback occurs through the inhibition of insulin receptor substrate function.
  • This regulatory mechanism provides a novel insight into pathway control.

Conclusions:

  • The characterized negative feedback loop involving mTOR and S6K is a key regulator of the phosphoinositide 3-kinase-Akt pathway.
  • This finding offers a new understanding of the pathophysiology of metabolic disorders and cancer.
  • Targeting this feedback loop may present therapeutic opportunities for diabetes, obesity, and cancer treatment.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Assessment of the Metabolic Profile of Primary Leukemia Cells06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Homeostatic Imbalance01:10

Homeostatic Imbalance

Homeostasis is the maintenance of a stable internal environment within the body, which is crucial for the proper functioning of cells, tissues, organs, and organ systems. The body has various control mechanisms that work together to regulate various physiological parameters such as temperature, blood pressure, pH balance, and fluid balance, to name a few. These control mechanisms are based on feedback loops that can be either positive or negative.
However, sometimes these feedback loops fail,...